Teaching
Modules for 2024-25
ANTIMICROBIAL CHEMOTHERAPY FOR CHEMISTS
Module code: LIFE348
Role: Teaching
Chemotherapy and Cellular Pharmacology
Module code: LIFE312
Role: Teaching
PHARMACOLOGY RESEARCH PROJECTS
Module code: PHAR660
Role: Teaching
Supervised Theses
- Assessing the relationship between nanoparticle physicochemical characteristics and biological interactions : optimisation of in vitro techniques and protocols
- Assessment of degradation rate constants for quantitative predictions of drug-drug interactions arising from CYP450 drug metabolising enzymes
- Assessment of the inter-individual variation observed between patients receiving HIV antiretroviral therapy
- Computational pharmacokinetics of long-acting formulations for the treatment of HIV infections
- Dissolving Microarray Patches for Transdermal Delivery of Atovaquone
- Exploring the Applications of PBPK Modelling to Optimise HIV-1 Treatment
- INVESTIGATION OF MOLECULAR MECHANISMS REGULATING DRUG-DRUG INTERACTIONS IN ANTIRETROVIRAL THERAPY
- In vitro, in vivo and in silico approaches to investigate pharmacokinetics and pharmacogenetics in HIV therapy
- Integrated Experimental and Computational Approaches for the Prediction of Drug-Drug Interactions
- Investigating the impact of, novel, therapeutic delivery systems on immunological responses - determination of short, and long-term, exposure effects
- Investigating the potential mechanisms behind the immunological responses to liposomes – links to cardiovascular complications
- Investigation of Long-acting Antiretroviral Nanoformulation Pharmacokinetics Using Experimental and Computational Methods
- Nanoparticle Interventions for Colorectal Cancer: Delivery of Polymer Encapsulated SN-38
- PBPK Modelling for the Prediction of Iron Oxide Nanoparticle Systemic and Intratumoural Distribution in Prostate and Pancreatic Cancers – Towards their Application in Hyperthermia Treatment
- THE PHARMACOKINETICS, PHARMACODYNAMICS AND PHARMACOGENETICS OF DOLUTEGRAVIR AND COBICISTAT IN THE TREATMENT OF HIV
- The use of Pharmacokinetics to Optimise Dosing and Reformulation of Antiretrovirals for Treatment and Prevention